NuCana is trading at $1.02, up +7.90% in after-hours trading, with no clear company-specific catalyst identified for November 6. - The latest reported company news was its September 30 European patent announcement. - Biotechnology shares rose during Friday’s session, and the iShares Biotechnology ETF was up 1.9%; available reports do not connect that sector move directly to NuCana’s after-hours gain.